GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (FRA:LDZA) » Definitions » Market Cap

Aspen Pharmacare Holdings (FRA:LDZA) Market Cap : €4,798 Mil (As of Apr. 28, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Aspen Pharmacare Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aspen Pharmacare Holdings's share price for the quarter that ended in Dec. 2023 was €9.6. Aspen Pharmacare Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 444 Mil. Therefore, Aspen Pharmacare Holdings's market cap for the quarter that ended in Dec. 2023 was €4,265 Mil.

Aspen Pharmacare Holdings's quarterly market cap increased from Dec. 2022 (€3,265 Mil) to Jun. 2023 (€3,865 Mil) and increased from Jun. 2023 (€3,865 Mil) to Dec. 2023 (€4,265 Mil).

Aspen Pharmacare Holdings's annual market cap declined from Jun. 2021 (€4,188 Mil) to Jun. 2022 (€3,782 Mil) but then increased from Jun. 2022 (€3,782 Mil) to Jun. 2023 (€3,865 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aspen Pharmacare Holdings's Enterprise Value for Today is €5,998 Mil.


Aspen Pharmacare Holdings Market Cap Historical Data

The historical data trend for Aspen Pharmacare Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Market Cap Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,789.50 3,370.86 4,187.52 3,782.04 3,864.87

Aspen Pharmacare Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,598.53 3,782.04 3,265.15 3,864.87 4,265.28

Competitive Comparison of Aspen Pharmacare Holdings's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's Market Cap falls into.



Aspen Pharmacare Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Aspen Pharmacare Holdings's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )=Share Price (A: Jun. 2023 )*Shares Outstanding (EOP) (A: Jun. 2023 )
=€8.7*444.238
=€3,865

Aspen Pharmacare Holdings's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€9.6*444.300
=€4,265

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aspen Pharmacare Holdings  (FRA:LDZA) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Aspen Pharmacare Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspen Pharmacare Holdings (FRA:LDZA) Business Description

Traded in Other Exchanges
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (FRA:LDZA) Headlines

No Headlines